Erratum (DOI:10.1016/j.cancergencyto.2009.06.013);Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study

Cancer Genetics and Cytogenetics

Volumn 195, Issue 1, 2009, Pages 59-65

  Kim, Miyoung ^a   Yim, Seon Hee ^b   Cho, Nam Sun ^c   Kang, Seong Ho ^d   Ko, Dae Hyun ^a   Oh, Bora ^e   Kim, Tae Young ^e   Min, Hyun Jung ^e   She, Cha Ja ^a   Kang, Hyoung Jin ^a   Shin, Hee Yung ^a   Ahn, Hyo Sup ^a   Yoon, Sung Soo ^a   Kim, Byoung Kook ^a   Shin, Hai Rim ^b   Han, Kyu Sup ^a   Cho, Han Ik ^f   Lee, Dong Soon ^a,e  

^a Seoul National University Hospital   (South Korea)

^b National Cancer Center   (South Korea)

^c BLOOD RESEARCH INSTITUTE   (United States)

^d Green Cross Company   (South Korea)

^e Seoul National University College of Medicine   (South Korea)

^f Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; MIXED LINEAGE LEUKEMIA PROTEIN; PROTEIN P14; PROTEIN P15; PROTEIN P16; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CANCER INCIDENCE; CANCER SURVIVAL; CHILD; CHROMOSOME 9P; CHROMOSOME DELETION; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE DELETION; GENE REARRANGEMENT; GENETIC ASSOCIATION; HEMIZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION;

EID: 70349876858     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.12.008     Document Type: Erratum

References (34)

1. Garcia-Manero G., Daniel J., Smith T.L., Kornblau S.M., Lee M.S., Kantarjian H.M., and Issa J.P. DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia. Clin Cancer Res 8 (2002) 2217-2224
2. Garcia-Manero G., Jeha S., Daniel J., Williamson J., Albitar M., Kantarjian H.M., and Issa J.P. Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemia. Cancer 97 (2003) 695-702
3. Pui C.H., Robison L.L., and Look A.T. Acute lymphoblastic leukemia. Lancet 371 (2008) 1030-1043
4. Belson M., Kingsley B., and Holmes A. Risk factors for acute lymphoblastic leukemia in children: a review. Environ Health Perspect 115 (2007) 138-145
5. Gökbuget N., and Hoelzer D. Treatment of adult acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program (2006) 133-141
6. Graf Einsiedel H., Taube T., Hartmann R., Eckert C., Seifert G., Wellmann S., Henze G., and Seeger K. Prognostic value of p16(INK4a) gene deletions in pediatric acute lymphoblastic leukemia. Blood 97 (2001) 4002-4004
7. Garcia-Manero G. Methylation, aging, and pediatric acute lymphocytic leukemia. Leukemia 17 (2003) 2063-2064
8. INK4B CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. Blood 94 (1999) 2445-2451
9. INK4b deletions in adult acute lymphoblastic leukemia. Clin Cancer Res 5 (1999) 1855-1861
10. INK4a deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse. Blood 97 (2001) 572-574
11. Kees U.R., Burton P.R., Lü C., and Baker D.L. Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome. Blood 89 (1997) 4161-4166
12. INK4a genes and location of the primary site in pulmonary squamous cell carcinoma. Pathol Int 54 (2004) 549-555
13. ARF)/ CDKN2B (p15) gene inactivation in malignant gliomas. Acta Neuropathol 98 (1999) 444-452
14. Foster S.A., Wong D.J., Barrett M.T., and Galloway D.A. Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol 18 (1998) 1793-1801
15. INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer. Cancer Epidemiol Biomarkers Prev 8 (1999) 501-506
16. INK4a prevents centrosome dysfunction and genomic instability in primary cells. PLoS Biol 4 (2006) 350-365 (e51)
17. Wong I.H. Methylation profiling of human cancers in blood: molecular monitoring and prognostication. Int J Oncol 19 (2001) 1319-1324
18. Matsushita C., Yang Y., Takeuchi S., Matsushita M., Van Dongen J.J., Szczepanski T., Bartram C.R., Seo H., Koeffler H.P., and Taguchi H. Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia. Oncol Rep 12 (2004) 97-99
19. INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res 5 (1999) 2704-2713
20. INK4a characterize the major types of hematological malignancies. Cancer Res 57 (1997) 837-841
21. Yang Y., Takeuchi S., Hofmann W.K., Ikezoe T., van Dongen J.J., Szczepański T., Bartram C.R., Yoshino N., Taguchi H., and Koeffler H.P. Aberrant methylation in promoter-associated CpG islands of multiple genes in acute lymphoblastic leukemia. Leuk Res 30 (2006) 98-102
22. Carter T.L., Reaman G.H., and Kees U.R. INK4A/ARF deletions are acquired at relapse in childhood acute lymphoblastic leukaemia: a paired study on 25 patients using real-time polymerase chain reaction. Br J Haematol 113 (2001) 323-328
23. Gutierrez M.I., Siraj A.K., Bhargava M., Ozbek U., Banavali S., Chaudhary M.A., El Solh H., and Bhatia K. Concurrent methylation of multiple genes in childhood ALL: correlation with phenotype and molecular subgroup. Leukemia 17 (2003) 1845-1850
24. Nakamura M., Sugita K., Inukai T., Goi K., Iijima K., Tezuka T., Kojika S., Shiraishi K., Miyamoto N., Karakida N., Kagami K., O-Koyama T., Mori T., and Nakazawa S. p16/MTS1/INK4A gene is frequently inactivated by hypermethylation in childhood acute lymphoblastic leukemia with 11q23 translocation. Leukemia 13 (1999) 884-890
25. + adult B-cell precursor acute lymphoblastic leukemia: impact on the clinical, biological and immunophenotypical disease characteristics. Leukemia 19 (2005) 713-720
26. National Committee for Clinical Laboratory Standards (NCCLS). Fluorescence in situ hybridization (FISH) methods for medical genetics; approved guideline. NCCLS Document MM7-A. ISBN 1-56238-524-0 (2004), NCCLS, Wayne, PA
27. In: Shaffer L.G., and Tommerup N. (Eds). ISCN 2005: an international system for human cytogenetic nomenclature (2005) (2005), S. Karger, Basel
28. Czepulkowski B. Basic techniques for the preparation and analysis of chromosomes from bone marrow and leukaemic blood. In: Rooney D.E. (Ed). Human cytogenetics: malignancy and acquired abnormalities. 3rd ed (2001), Oxford University Press, Oxford 1-26
29. Herman J.G., Graff J.R., Myöhänen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93 (1996) 9821-9826
30. Smith M., Arthur D., Camitta B., Carroll A.J., Crist W., Gaynon P., Gelber R., Heerema N., Korn E.L., Link M., Murphy S., Pui C.H., Pullen J., Reamon G., Sallan S.E., Sather H., Shuster J., Simon R., Trigg M., Tubergen D., Uckun F., and Ungerleider R. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 14 (1996) 18-24
31. Niida H., and Nakanishi M. DNA damage checkpoints in mammals. Mutagenesis 21 (2006) 3-9
32. Drexler H.G. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia 12 (1998) 845-859
33. Reato G., Basso G., Putti M.C., Cignetti A., Guarini A., and Foa R. Microsatellite analysis in childhood acute lymphoblastic leukemia. Haematologica 83 (1998) 403-407
34. Gonzalez-Paz N., Chng W.J., McClure R.F., Blood E., Oken M.M., Van Ness B., James C.D., Kurtin P.J., Henderson K., Ahmann G.J., Gertz M., Lacy M., Dispenzieri A., Greipp P.R., and Fonseca R. Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications. Blood 109 (2007) 1228-1232